← SynDRA
AMIKACIN
SynDRA canonical compound SYN0006026 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | bacterial 30S ribosomal subunit inhibitor |
|---|
| Indication | gram-negative bacterial infections |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
- bacterial 30S ribosomal subunit inhibitor
- Binder
Drug classes
- Aminoglycoside Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- S01A · ANTIINFECTIVES
- D06A · ANTIBIOTICS FOR TOPICAL USE
- J01G · AMINOGLYCOSIDE ANTIBACTERIALS
- COMBINATIONS OF ANTIBACTERIALS
Cross-references
Synonyms
- amicacin
- amikacillin
- arikace
- lukadin
- amikacin sulfate
- amikacin hydrate
- Amikacine
- Amikacina
- Amikacinum
- Lukadin
- Potentox
- BAY 41-6551
- NSC-177001
- Amicacin
- Amikavet
- Amikin
- Arikace
- Briclin
- Kaminax
- Mikavir
- AMIKACIN SULFATE
- Amikacin Base
- Amikacin Dihydrate
- ANTIBIOTIC BB-K8
- Amiglyde-V
- Amikacin & Tumor Necrosis Factor
- Amikacin (USP)
- Amikacina [INN-Spanish]
- Amikacine [INN-French]
- Amikacinum [INN-Latin]
- Amikin(Disulfate)
- Antibiotic BB-K 8
- BB-K 8
- BB-K8
- Amiglyde-V (TN)
- Amikacin (USP/INN)
- Amikacin [USAN:BAN:INN]
- O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-6))-N(sup 3)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-L-streptamine
Reported adverse events
- Rash
- Vomiting
- Nausea
- Pyrexia
- Anxiety
- Bronchitis
- Bronchospasm
- Chest discomfort
- Cough
- Dry mouth
- Dysgeusia
- Dysphonia
Look up AMIKACIN in the interactive SynDRA portal →